In the control mice group, the calculated PTZ CD50 was 61.96 mg/kg and in the mice without DSS-induced colitis, only VPA (600 mg/kg) was able to significantly increase the CD50 (89.94 mg/kg) whereas the other treatments (ALAC, NaB and MSZ) were not effective. This evidence concerns the gene ICAM3 and colitis.